Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
March 11, 2021 21:44 ET | Source: Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc. San Diego, California, UNITED STATES
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $16.00 per share. The gross proceeds to Longboard from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $80.0 million.
Longboard was formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GP
Municipals outperform UST sell-off bondbuyer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bondbuyer.com Daily Mail and Mail on Sunday newspapers.
Contrasting January, where markets remained relatively wary of the risks posed - particularly as the number of reported coronavirus cases continued to rise, following both the festive period and due to the newly emerging virus variants - February proved positive for corporate credit.
The risk-on mode drove government bond yields, which move inversely to price, higher while corporate credit advanced.
Following a mixed start in the first month of the year, corporate credit, contrasting government bonds which saw a sharp sell-off, particularly in late February, performed well. Investor optimism, fuelled by improving economic conditions offset lingering doubts surrounding the health crisis, which to-date, seem far from abating.
SoftBank s SVF Investment Corp 3 Announces Closing of $320,000,000 Million Initial Public Offering prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.